Market Cap
Low in industry
PE TTM
Negative PE TTM
PEG TTM
Price to Book
Negative Price to Book
Beta 1Year
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Elliot Cooperstone | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.59 per share. | 30 Jan 2024 | 8,935 | 517,107 | - | 2.6 | 23,177 | Class A Common Stock |
| Elliot Cooperstone | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.53 per share. | 30 Jan 2024 | 1,100 | 516,007 | - | 2.5 | 2,780 | Class A Common Stock |
| Cooperstone Elliot | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.70 per share. | 30 Jan 2024 | 12,703 | 526,042 | - | 2.7 | 34,285 | Class A Common Stock |
| Cooperstone Elliot | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.74 per share. | 25 Jan 2024 | 41,357 | 538,745 | - | 2.7 | 113,471 | Class A Common Stock |
| Elliot Cooperstone | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.58 per share. | 25 Jan 2024 | 18,569 | 612,795 | - | 2.6 | 47,960 | Class A Common Stock |
| Elliot Cooperstone | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.74 per share. | 25 Jan 2024 | 32,693 | 580,102 | - | 2.7 | 89,736 | Class A Common Stock |
| Elliot Cooperstone | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.50 per share. | 22 Jan 2024 | 125,000 | 740,206 | - | 2.5 | 312,763 | Class A Common Stock |
| Elliot Cooperstone | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.84 per share. | 22 Jan 2024 | 35,808 | 631,364 | - | 2.8 | 101,612 | Class A Common Stock |
| Elliot Cooperstone | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.94 per share. | 22 Jan 2024 | 73,034 | 667,172 | - | 2.9 | 214,800 | Class A Common Stock |
| Cooperstone Elliot | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.91 per share. | 17 Jan 2024 | 100,000 | 865,206 | - | 1.9 | 191,250 | Class A Common Stock |
| Cooperstone Elliot | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.28 per share. | 17 Jan 2024 | 94,013 | 971,193 | - | 2.3 | 214,058 | Class A Common Stock |
| Cooperstone Elliot | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.92 per share. | 17 Jan 2024 | 5,987 | 965,206 | - | 2.9 | 17,489 | Class A Common Stock |
| Cooperstone Elliot | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.59 per share. | 10 Jan 2024 | 25,000 | 24,171 | - | 3.6 | 89,790 | Class A Common Stock |
| Elliot Cooperstone | Ten Percent Owner | 10 Jan 2024 | 1,065,206 | 1,065,206 | - | - | PCIH Common Units | ||
| Elliot Cooperstone | Ten Percent Owner | 10 Jan 2024 | 1,065,206 | 0 | - | - | Class B Common Stock | ||
| Cooperstone Elliot | Ten Percent Owner | 10 Jan 2024 | 1,065,206 | 1,065,206 | - | - | Class A Common Stock | ||
| Cooperstone Elliot | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.73 per share. | 10 Jan 2024 | 25,000 | 49,171 | - | 3.7 | 93,293 | Class A Common Stock |
| Elliot Cooperstone | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.30 per share. | 10 Jan 2024 | 24,171 | 0 | - | 3.3 | 79,878 | Class A Common Stock |
| Elliot Cooperstone | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.82 per share. | 05 Jan 2024 | 25,000 | 99,171 | - | 3.8 | 95,553 | Class A Common Stock |
| Cooperstone Elliot | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.85 per share. | 05 Jan 2024 | 25,000 | 124,171 | - | 3.8 | 96,233 | Class A Common Stock |
| Cooperstone Elliot | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.75 per share. | 05 Jan 2024 | 25,000 | 74,171 | - | 3.7 | 93,673 | Class A Common Stock |
| Elliot Cooperstone | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.42 per share. | 02 Jan 2024 | 43,505 | 237,499 | - | 5.4 | 235,658 | Class A Common Stock |
| Elliot Cooperstone | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 02 Jan 2024 | 13,328 | 149,171 | - | 4.0 | 53,297 | Class A Common Stock |
| Cooperstone Elliot | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.94 per share. | 02 Jan 2024 | 24,182 | 162,499 | - | 4.9 | 119,423 | Class A Common Stock |
| Cooperstone Elliot | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.08 per share. | 02 Jan 2024 | 50,818 | 186,681 | - | 4.1 | 207,251 | Class A Common Stock |
| Elliot Cooperstone | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.00 per share. | 27 Dec 2023 | 35,112 | 281,004 | - | 6.0 | 210,644 | Class A Common Stock |
| Elliot Cooperstone | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.00 per share. | 27 Dec 2023 | 41,197 | 316,116 | - | 6.0 | 247,227 | Class A Common Stock |
| Cooperstone Elliot | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.65 per share. | 27 Dec 2023 | 37,607 | 357,313 | - | 5.6 | 212,370 | Class A Common Stock |
| Elliot Cooperstone | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.65 per share. | 21 Dec 2023 | 27,377 | 416,074 | - | 5.7 | 154,787 | Class A Common Stock |
| Elliot Cooperstone | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.44 per share. | 21 Dec 2023 | 21,154 | 394,920 | - | 5.4 | 115,124 | Class A Common Stock |
| Elliot Cooperstone | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.62 per share. | 21 Dec 2023 | 6,309 | 443,451 | - | 6.6 | 41,765 | Class A Common Stock |
| Elliot Cooperstone | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.67 per share. | 21 Dec 2023 | 82,843 | 449,760 | - | 5.7 | 469,430 | Class A Common Stock |
| Elliot Cooperstone | Ten Percent Owner | 15 Dec 2023 | 532,603 | 1,065,206 | - | - | PCIH Common Units | ||
| Cooperstone Elliot | Ten Percent Owner | 15 Dec 2023 | 532,603 | 1,065,206 | - | - | Class B Common Stock | ||
| Elliot Cooperstone | Ten Percent Owner | 15 Dec 2023 | 532,603 | 532,603 | - | - | Class A Common Stock | ||
| D. Solomon Trujillo | Director | 07 Dec 2023 | 136,804 | 0 | - | - | Class B Common Stock | ||
| Solomon Trujillo D. | Director | 07 Dec 2023 | 136,804 | 0 | - | - | PCIH Common Units | ||
| D. Trujillo Solomon | Director | 07 Dec 2023 | 136,804 | 136,804 | - | - | Class A Common Stock | ||
| Angel L. Morales | Director | 20 Nov 2023 | 69,685 | 0 | - | - | PCIH Common Units | ||
| Angel L. Morales | Director | 20 Nov 2023 | 69,685 | 69,685 | - | - | Class A Common Stock | ||
| Angel L. Morales | Director | 20 Nov 2023 | 69,685 | 0 | - | - | Class B Common Stock | ||
| Eladio Gil | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2023 | 7,676 | 7,676 | - | 0 | Class A Common Stock | |
| Robert Camerlinck | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.77 per share. | 11 Aug 2023 | 30,646 | 26,958,642 | - | 0.8 | 23,453 | Class A Common Stock |
| Marlow Hernandez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2023 | 189,681 | 4,942,605 | - | - | Class A Common Stock | |
| DeMarquette D. Kent | Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2023 | 1,138,088 | 1,529,694 | - | - | Class A Common Stock | |
| DeMarquette D. Kent | Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2023 | 216,237 | 391,606 | - | - | Class A Common Stock | |
| David Armstrong | See remarks | Grant, award, or other acquisition of securities at price $ 0.77 per share. | 30 Jun 2023 | 7,506 | 664,132 | - | 0.8 | 5,780 | Class A Common Stock |
| Richard Aguilar | Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 1.31 per share. | 28 Jun 2023 | 400,000 | 1,213,984 | - | 1.3 | 525,760 | Class A Common Stock |
| Richard Aguilar | Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 1.22 per share. | 28 Jun 2023 | 150,000 | 1,613,984 | - | 1.2 | 183,300 | Class A Common Stock |
| Richard Aguilar | Chief Clinical Officer | 26 Jun 2023 | 550,000 | 1,763,984 | - | 0 | Class A Common Stock | ||
| Richard Aguilar | Chief Clinical Officer | 26 Jun 2023 | 550,000 | 4,742,276 | - | - | Class B Common Stock | ||
| Richard Aguilar | Chief Clinical Officer | 26 Jun 2023 | 550,000 | 4,742,276 | - | - | PCIH Common Units | ||
| Alan M. Muney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 185,598 | 248,500 | - | - | Class A Common Stock | |
| Solomon D. Trujillo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 211,581 | 378,214 | - | - | Class A Common Stock | |
| Kim M. Rivera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 185,598 | 248,500 | - | - | Class A Common Stock | |
| Angel L. Morales | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 185,598 | 248,500 | - | - | Class A Common Stock | |
| Jacqueline Guichelaar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 185,598 | 248,500 | - | - | Class A Common Stock | |
| David Armstrong | See remarks | Sale of securities on an exchange or to another person at price $ 1.38 per share. | 06 Jun 2023 | 3,163 | 656,626 | - | 1.4 | 4,351 | Class A Common Stock |
| Marlow Hernandez | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 671,742 | 4,701,256 | - | - | Class A Common Stock | |
| Brian D. Koppy | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 248,226 | 1,050,796 | - | - | Class A Common Stock | |
| Richard Aguilar | Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 231,008 | 1,213,984 | - | - | Class A Common Stock | |
| David Armstrong | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 109,526 | 659,789 | - | - | Class A Common Stock | |
| Mark Novell | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 60,502 | 232,067 | - | - | Class A Common Stock | |
| Robert Camerlinck | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 239,139 | 26,989,288 | - | - | Class A Common Stock | |
| Richard Aguilar | Chief Clinical Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 25 May 2023 | 600,000 | 2,089,924 | - | 0 | Class A Common Stock | |
| Richard Aguilar | Chief Clinical Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 25 May 2023 | 600,000 | 0 | - | 0 | Class A Common Stock | |
| Richard Aguilar | Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 1.32 per share. | 25 May 2023 | 400,000 | 1,489,924 | - | 1.3 | 528,400 | Class A Common Stock |
| Richard Aguilar | Chief Clinical Officer | 25 May 2023 | 600,000 | 600,000 | - | 0 | Class A Common Stock | ||
| Richard Aguilar | Chief Clinical Officer | 25 May 2023 | 675,940 | 1,889,924 | - | 0 | Class A Common Stock | ||
| Richard Aguilar | Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 1.29 per share. | 25 May 2023 | 275,940 | 1,813,984 | - | 1.3 | 356,156 | Class A Common Stock |
| Richard Aguilar | Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 1.38 per share. | 25 May 2023 | 100,000 | 1,713,984 | - | 1.4 | 137,760 | Class A Common Stock |
| Richard Aguilar | Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 1.42 per share. | 25 May 2023 | 500,000 | 1,213,984 | - | 1.4 | 711,650 | Class A Common Stock |
| Richard Aguilar | Chief Clinical Officer | 25 May 2023 | 675,940 | 0 | - | - | PCIH Common Units | ||
| Richard Aguilar | Chief Clinical Officer | 25 May 2023 | 675,940 | 0 | - | - | Class B Common Stock | ||
| Richard Aguilar | Chief Clinical Officer | 25 May 2023 | 600,000 | 5,292,276 | - | - | PCIH Common Units | ||
| Richard Aguilar | Chief Clinical Officer | 25 May 2023 | 600,000 | 5,292,276 | - | - | Class B Common Stock | ||
| Mark Novell | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2023 | 32,131 | 32,131 | - | - | Stock Option (Right to Buy) | |
| Mark Novell | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2023 | 51,684 | 171,565 | - | - | Class A Common Stock | |
| Marlow Hernandez | Director, CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 05 Apr 2023 | 8,536,936 | 13,497,686 | - | - | PCIH Common Units | |
| Marlow Hernandez | Director, CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 05 Apr 2023 | 8,536,936 | 8,536,936 | - | - | Call option (right to buy) | |
| Marlow Hernandez | Director, CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 05 Apr 2023 | 8,536,936 | 13,497,686 | - | - | Class B Common Stock | |
| Brian D. Koppy | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.27 per share. | 05 Apr 2023 | 23,591 | 802,570 | - | 1.3 | 30,067 | Class A Common Stock |
| Richard Aguilar | Chief Clinical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 05 Apr 2023 | 4,991,807 | 4,991,807 | - | - | Call option (right to buy) | |
| Richard Aguilar | Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 05 Apr 2023 | 4,991,807 | 5,892,276 | - | - | Class B Common Stock | |
| Richard Aguilar | Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 05 Apr 2023 | 4,991,807 | 5,892,276 | - | - | PCIH Common Units | |
| Robert Camerlinck | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 05 Apr 2023 | 20,000,000 | 0 | - | - | Put option (obligation to sell) | |
| Robert Camerlinck | Chief Operating Officer | Other type of transaction at price $ 0.00 per share. | 05 Apr 2023 | 17,163,460 | 17,163,460 | - | - | Class B Common Stock | |
| Robert Camerlinck | Chief Operating Officer | Other type of transaction at price $ 0.00 per share. | 05 Apr 2023 | 17,163,460 | 17,163,460 | - | - | PCIH Common Units | |
| Robert Camerlinck | Chief Operating Officer | Other type of transaction at price $ 0.00 per share. | 05 Apr 2023 | 2,836,540 | 26,750,149 | - | - | Class A Common Stock | |
| Marlow Hernandez | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 348,604 | 4,029,514 | - | - | Class A Common Stock | |
| Marlow Hernandez | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 729,730 | 729,730 | - | - | Stock Option (Right to Buy) | |
| Brian D. Koppy | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 260,000 | 260,000 | - | - | Stock Option (Right to Buy) | |
| Brian D. Koppy | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 124,206 | 826,161 | - | - | Class A Common Stock | |
| Richard Aguilar | Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 120,116 | 982,976 | - | - | Class A Common Stock | |
| Richard Aguilar | Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 195,676 | 195,676 | - | - | Stock Option (Right to Buy) | |
| David Armstrong | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 146,757 | 146,757 | - | - | Stock Option (Right to Buy) | |
| David Armstrong | See remarks | 31 Mar 2023 | 185,000 | 841,626 | - | 0 | Class A Common Stock | ||
| David Armstrong | See remarks | 31 Mar 2023 | 185,000 | 689,453 | - | - | Class B Common Stock | ||
| David Armstrong | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 70,108 | 550,263 | - | - | Class A Common Stock | |
| David Armstrong | See remarks | 31 Mar 2023 | 185,000 | 689,453 | - | - | PCIH Common Units | ||
| Robert Camerlinck | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 147,548 | 147,548 | - | - | Stock Option (Right to Buy) | |
| Robert Camerlinck | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 70,486 | 23,913,609 | - | - | Class A Common Stock | |
| Brian D. Koppy | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.08 per share. | 05 Jan 2023 | 28,528 | 701,955 | - | 1.1 | 30,673 | Class A Common Stock |
| Richard Aguilar | Chief Clinical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.08 per share. | 05 Jan 2023 | 27,010 | 862,860 | - | 1.1 | 29,041 | Class A Common Stock |
| David Armstrong | See remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.08 per share. | 05 Jan 2023 | 19,749 | 480,155 | - | 1.1 | 21,234 | Class A Common Stock |
| Mark Novell | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.08 per share. | 05 Jan 2023 | 4,538 | 119,881 | - | 1.1 | 4,879 | Class A Common Stock |
| Marlow Hernandez | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.87 per share. | 03 Jan 2023 | 134,660 | 3,680,910 | - | 0.9 | 116,750 | Class A Common Stock |
| David Armstrong | See remarks | Grant, award, or other acquisition of securities at price $ 0.87 per share. | 03 Jan 2023 | 13,006 | 499,904 | - | 0.9 | 11,276 | Class A Common Stock |
| Robert Camerlinck | Chief Operating Officer | Other type of transaction at price $ 0.00 per share. | 01 Sep 2022 | 25,386 | 23,843,123 | - | - | Class A Common Stock | |
| Brian D. Koppy | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.95 per share. | 31 Aug 2022 | 13,651 | 730,483 | - | 6.0 | 81,243 | Class A Common Stock |
| David Armstrong | See remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.95 per share. | 31 Aug 2022 | 20,500 | 486,898 | - | 6.0 | 122,006 | Class A Common Stock |
| Mark Novell | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.95 per share. | 31 Aug 2022 | 7,387 | 124,419 | - | 6.0 | 43,964 | Class A Common Stock |
| Mark Novell | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 24,000 | 131,806 | - | - | Class A Common Stock | |
| Robert Camerlinck | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 250,000 | 23,817,737 | - | - | Class A Common Stock | |
| Marlow Hernandez | Director, CEO | Grant, award, or other acquisition of securities at price $ 3.52 per share. | 05 Jul 2022 | 29,870 | 3,546,250 | - | 3.5 | 105,142 | Class A Common Stock |
| David Armstrong | See remarks | Grant, award, or other acquisition of securities at price $ 3.52 per share. | 05 Jul 2022 | 4,828 | 507,398 | - | 3.5 | 16,995 | Class A Common Stock |
| David Armstrong | See remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.13 per share. | 07 Jun 2022 | 3,254 | 502,570 | - | 5.1 | 16,709 | Class A Common Stock |
| Marlow Hernandez | Director, CEO | Other type of transaction at price $ 0.00 per share. | 26 May 2022 | 11,017,311 | 22,034,622 | - | - | PCIH Common Units | |
| Marlow Hernandez | Director, CEO | Other type of transaction at price $ 0.00 per share. | 26 May 2022 | 11,017,311 | 0 | - | 0 | Class A Common Stock | |
| Marlow Hernandez | Director, CEO | Other type of transaction at price $ 0.00 per share. | 26 May 2022 | 11,017,311 | 22,034,622 | - | - | Class B Common Stock | |
| Alan M. Muney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2022 | 48,077 | 62,902 | - | - | Class A Common Stock | |
| Solomon D. Trujillo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2022 | 54,808 | 166,633 | - | - | Class A Common Stock | |
| Barry S. Sternlicht | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2022 | 48,077 | 12,854,233 | - | - | Class A Common Stock | |
| Kim M. Rivera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2022 | 48,077 | 62,902 | - | - | Class A Common Stock | |
| Angel L. Morales | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2022 | 48,077 | 62,902 | - | - | Class A Common Stock | |
| Lewis Gold | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2022 | 48,077 | 362,902 | - | - | Class A Common Stock | |
| Elliot Cooperstone | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2022 | 48,077 | 62,902 | - | - | Class A Common Stock | |
| Jacqueline Guichelaar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2022 | 48,077 | 62,902 | - | - | Class A Common Stock | |
| Brian D. Koppy | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.38 per share. | 09 May 2022 | 40,484 | 744,134 | - | 4.4 | 177,320 | Class A Common Stock |
| Lewis Gold | Director | 17 Mar 2022 | 10,000 | 1,233,085 | - | 0 | Class A Common Stock | ||
| Lewis Gold | Director | Purchase of securities on an exchange or from another person at price $ 6.81 per share. | 17 Mar 2022 | 300,000 | 314,825 | - | 6.8 | 2,043,000 | Class A Common Stock |
| Lewis Gold | Director | 17 Mar 2022 | 10,000 | 1,233,085 | - | - | Class B Common Stock | ||
| Lewis Gold | Director | 17 Mar 2022 | 10,000 | 1,233,085 | - | - | PCIH Common Units | ||
| Marlow Hernandez | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 139,175 | 139,175 | - | - | Stock Option (Right to Buy) | |
| Marlow Hernandez | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 624,418 | 3,516,380 | - | - | Class A Common Stock | |
| Brian D. Koppy | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 36,681 | 36,681 | - | - | Stock Option (Right to Buy) | |
| Brian D. Koppy | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 181,280 | 784,618 | - | - | Class A Common Stock | |
| Richard Aguilar | Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 37,320 | 37,320 | - | - | Stock Option (Right to Buy) | |
| Richard Aguilar | Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 171,641 | 889,870 | - | - | Class A Common Stock | |
| David Armstrong | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 27,990 | 27,990 | - | - | Stock Option (Right to Buy) | |
| David Armstrong | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 125,474 | 505,824 | - | - | Class A Common Stock | |
| Mark Novell | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 6,449 | 6,449 | - | - | Stock Option (Right to Buy) | |
| Mark Novell | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 50,000 | 107,806 | - | - | Class A Common Stock | |
| Mark Novell | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 28,783 | 57,806 | - | - | Class A Common Stock | |
| Lewis Gold | Director | 07 Feb 2022 | 158,850 | 158,850 | - | 0 | Class A Common Stock | ||
| Lewis Gold | Director | 07 Feb 2022 | 1,223,085 | 1,223,085 | - | - | PCIH Common Units | ||
| Lewis Gold | Director | 07 Feb 2022 | 1,223,085 | 1,223,085 | - | - | Class B Common Stock | ||
| Lewis Gold | Director | 07 Feb 2022 | 158,850 | 158,850 | - | - | PCIH Common Units | ||
| Lewis Gold | Director | 07 Feb 2022 | 158,850 | 158,850 | - | - | Class B Common Stock | ||
| Lewis Gold | Director | 07 Feb 2022 | 1,223,085 | 1,223,085 | - | 0 | Class A Common Stock | ||
| Alan M. Muney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 14,825 | 14,825 | - | - | Class A Common Stock | |
| Solomon D. Trujillo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 14,825 | 111,825 | - | - | Class A Common Stock | |
| Barry S. Sternlicht | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 14,825 | 14,825 | - | - | Class A Common Stock | |
| Kim M. Rivera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 14,825 | 14,825 | - | - | Class A Common Stock | |
| Angel L. Morales | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 14,825 | 14,825 | - | - | Class A Common Stock | |
| Lewis Gold | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 14,825 | 14,825 | - | - | Class A Common Stock | |
| Elliot Cooperstone | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 14,825 | 14,825 | - | - | Class A Common Stock | |
| Jacqueline Guichelaar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 14,825 | 14,825 | - | - | Class A Common Stock | |
| Richard Aguilar | Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 200,000 | 771,229 | - | - | Class A Common Stock | |
| David Armstrong | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 50,000 | 380,350 | - | - | Class A Common Stock | |
| Brian D. Koppy | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2022 | 373,972 | 603,338 | - | - | Class A Common Stock | |
| Richard Aguilar | Chief Clinical Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2021 | 11,000 | 723,229 | - | 0 | Class A Common Stock | |
| Richard Aguilar | Chief Clinical Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2021 | 12,000 | 759,229 | - | 0 | Class A Common Stock | |
| Richard Aguilar | Chief Clinical Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2021 | 25,000 | 734,229 | - | 0 | Class A Common Stock | |
| Richard Aguilar | Chief Clinical Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2021 | 5,000 | 718,229 | - | 0 | Class A Common Stock | |
| Richard Aguilar | Chief Clinical Officer | Other type of transaction at price $ 0.00 per share. | 22 Dec 2021 | 119,407 | 529,895 | - | - | Class A Common Stock | |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 06 Dec 2021 | 14,999 | 473,469 | - | - | Warrants to purchase Class A Common Stock | |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 06 Dec 2021 | 15,000 | 2,891,962 | - | 8 | 120,000 | Class A Common Stock |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 01 Dec 2021 | 22,001 | 458,470 | - | - | Warrants to purchase Class A Common Stock | |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 01 Dec 2021 | 10,000 | 436,469 | - | - | Warrants to purchase Class A Common Stock | |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 8.75 per share. | 01 Dec 2021 | 12,500 | 2,876,962 | - | 8.8 | 109,375 | Class A Common Stock |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 30 Nov 2021 | 15,000 | 426,469 | - | - | Warrants to purchase Class A Common Stock | |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Nov 2021 | 10,000 | 391,469 | - | - | Warrants to purchase Class A Common Stock | |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 9.65 per share. | 22 Nov 2021 | 8,000 | 2,864,462 | - | 9.7 | 77,200 | Class A Common Stock |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Nov 2021 | 20,000 | 411,469 | - | - | Warrants to purchase Class A Common Stock | |
| Solomon D. Trujillo | Director | Purchase of securities on an exchange or from another person at price $ 10.55 per share. | 18 Nov 2021 | 97,000 | 97,000 | - | 10.6 | 1,023,350 | Class A Common Stock |
| Marlow Hernandez | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2021 | 1,339,500 | 2,856,462 | - | - | Class A Common Stock | |
| Brian D. Koppy | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2021 | 190,000 | 190,000 | - | - | Class A Common Stock | |
| Richard Aguilar | Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2021 | 285,333 | 410,488 | - | - | Class A Common Stock | |
| David Armstrong | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2021 | 285,333 | 300,333 | - | - | Class A Common Stock | |
| Mark Novell | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2021 | 29,023 | 29,023 | - | - | Class A Common Stock | |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Sep 2021 | 70,000 | 70,000 | - | - | Class B Common Stock | |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Sep 2021 | 70,000 | 70,000 | - | - | PCIH Common Units | |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Aug 2021 | 94,311 | 381,469 | - | - | Warrants to purchase Class A Common Stock | |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 11.99 per share. | 31 Aug 2021 | 5,833 | 1,516,962 | - | 12.0 | 69,938 | Class A Common Stock |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 11.99 per share. | 31 Aug 2021 | 2,500 | 67,597 | - | 12.0 | 29,975 | Class A Common Stock |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Aug 2021 | 40,419 | 46,987 | - | - | Warrants to purchase Class A Common Stock | |
| Richard Aguilar | Chief Clinical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 30 Aug 2021 | 24,777 | 675,940 | - | - | Class B Common Stock | |
| Richard Aguilar | Chief Clinical Officer | Purchase of securities on an exchange or from another person at price $ 11.93 per share. | 30 Aug 2021 | 1,749 | 125,155 | - | 11.9 | 20,866 | Class A Common Stock |
| Richard Aguilar | Chief Clinical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 30 Aug 2021 | 24,777 | 675,940 | - | - | PCIH Common Units | |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 11.79 per share. | 25 Aug 2021 | 14,560 | 326,187 | - | 11.8 | 171,662 | Class A Common Stock |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Aug 2021 | 3,896 | 6,568 | - | - | Warrants to purchase Class A Common Stock | |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Aug 2021 | 9,091 | 287,158 | - | - | Warrants to purchase Class A Common Stock | |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Aug 2021 | 2,672 | 2,672 | - | - | Warrants to purchase Class A Common Stock | |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Aug 2021 | 6,235 | 278,067 | - | - | Warrants to purchase Class A Common Stock | |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 10.75 per share. | 25 Aug 2021 | 1,173,276 | 1,511,129 | - | 10.8 | 12,612,717 | Class A Common Stock |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 11.92 per share. | 25 Aug 2021 | 2,500 | 65,097 | - | 11.9 | 29,800 | Class A Common Stock |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 11.87 per share. | 25 Aug 2021 | 5,833 | 337,853 | - | 11.9 | 69,238 | Class A Common Stock |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 11.77 per share. | 25 Aug 2021 | 2,500 | 62,597 | - | 11.8 | 29,425 | Class A Common Stock |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 11.84 per share. | 25 Aug 2021 | 5,833 | 332,020 | - | 11.8 | 69,063 | Class A Common Stock |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 11.62 per share. | 25 Aug 2021 | 6,240 | 60,097 | - | 11.6 | 72,509 | Class A Common Stock |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 11.93 per share. | 25 Aug 2021 | 54,727 | 311,627 | - | 11.9 | 652,893 | Class A Common Stock |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 11.94 per share. | 25 Aug 2021 | 53,857 | 53,857 | - | 11.9 | 643,053 | Class A Common Stock |
| Richard Aguilar | Chief Clinical Officer | Purchase of securities on an exchange or from another person at price $ 11.93 per share. | 25 Aug 2021 | 51,393 | 51,393 | - | 11.9 | 613,118 | Class A Common Stock |
| Richard Aguilar | Chief Clinical Officer | Purchase of securities on an exchange or from another person at price $ 11.99 per share. | 25 Aug 2021 | 72,013 | 123,406 | - | 12.0 | 863,436 | Class A Common Stock |
| Richard Aguilar | Chief Clinical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Aug 2021 | 8,121 | 8,121 | - | - | Warrants to purchase Class A Common Stock | |
| Richard Aguilar | Chief Clinical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Aug 2021 | 38,589 | 46,710 | - | - | Warrants to purchase Class A Common Stock | |
| Richard Aguilar | Chief Clinical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Aug 2021 | 651,163 | 651,163 | - | - | Class B Common Stock | |
| Richard Aguilar | Chief Clinical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Aug 2021 | 651,163 | 651,163 | - | - | PCIH Common Units | |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Aug 2021 | 15,000 | 266,832 | - | - | Warrants to purchase Class A Common Stock | |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 10.38 per share. | 18 Aug 2021 | 25,000 | 246,900 | - | 10.4 | 259,500 | Class A Common Stock |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Aug 2021 | 5,000 | 271,832 | - | - | Warrants to purchase Class A Common Stock | |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 9.82 per share. | 18 Aug 2021 | 11,900 | 221,900 | - | 9.8 | 116,858 | Class A Common Stock |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Aug 2021 | 1,832 | 251,832 | - | - | Warrants to purchase Class A Common Stock | |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 10.20 per share. | 18 Aug 2021 | 10,000 | 256,900 | - | 10.2 | 102,000 | Class A Common Stock |
| David Armstrong | See remarks | Purchase of securities on an exchange or from another person at price $ 10.02 per share. | 18 Aug 2021 | 15,000 | 15,000 | - | 10.0 | 150,276 | Class A Common Stock |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 9.55 per share. | 16 Aug 2021 | 90,000 | 210,000 | - | 9.6 | 859,500 | Class A Common Stock |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Aug 2021 | 90,000 | 250,000 | - | - | Warrants to purchase Class A Common Stock | |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Aug 2021 | 160,000 | 160,000 | - | - | Warrants to purchase Class A Common Stock | |
| Marlow Hernandez | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 10.16 per share. | 16 Aug 2021 | 120,000 | 120,000 | - | 10.2 | 1,219,200 | Class A Common Stock |
| Barry S. Sternlicht | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 21 Jul 2021 | 2,688,694 | 7,844,639 | - | - | Warrants to purchase Class A common stock | |
| Barry S. Sternlicht | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 21 Jul 2021 | 4,383,669 | 34,831,848 | - | 0 | Class A common stock |